---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-011788"
form_type: "8-K"
ticker: "YCBD"
cik: "0001644903"
company_name: "cbdMD, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:13:21.791667+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# cbdMD shareholders approve automatic conversion of Series A Preferred Stock into common at 13:1

## Summary
- Shareholders approved automatic conversion of each Series A Preferred share into 13 common shares, eliminating $6.7M in accrued dividends and $4M annual dividend obligations.
- Seven directors elected: Bakari Sellers, William F. Raines III, Scott G. Stephen, Dr. Sybil Swift, T. Ronan Kennedy, Jeffrey Porter, Kevin Roe.
- Shareholders ratified Cherry Bekaert LLP as independent auditor for fiscal year ending Sept 30, 2025.
- Shareholders authorized reverse stock split at a ratio from 1:3 to 1:10, at Board's discretion within one year.
- CEO Ronan Kennedy stated conversion will strengthen balance sheet and enable strategic activity including M&A.

## SEC filing metadata
- accession: 0001437749-25-011788
- form_type: 8-K
- ticker: YCBD
- cik: 0001644903
- company_name: cbdMD, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644903/000143774925011788/0001437749-25-011788-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644903/000143774925011788/ycbd20250410_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-011788
- JSON: https://secwatch.observer/filing/0001437749-25-011788.json
- Plain text: https://secwatch.observer/filing/0001437749-25-011788.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.